Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Non Operating Income (2020 - 2025)

Bolt Biotherapeutics' Non Operating Income history spans 6 years, with the latest figure at $559000.0 for Q3 2025.

  • For Q3 2025, Non Operating Income fell 55.88% year-over-year to $559000.0; the TTM value through Sep 2025 reached $3.3 million, down 69.82%, while the annual FY2024 figure was $9.9 million, 41.88% up from the prior year.
  • Non Operating Income for Q3 2025 was $559000.0 at Bolt Biotherapeutics, down from $649000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $6.3 million in Q1 2024 and bottomed at -$6.0 million in Q1 2021.
  • The 5-year median for Non Operating Income is $980000.0 (2024), against an average of $822736.8.
  • The largest annual shift saw Non Operating Income plummeted 5482.14% in 2021 before it soared 1371.95% in 2022.
  • A 5-year view of Non Operating Income shows it stood at -$82000.0 in 2021, then skyrocketed by 1371.95% to $1.0 million in 2022, then surged by 78.62% to $1.9 million in 2023, then crashed by 47.4% to $980000.0 in 2024, then plummeted by 42.96% to $559000.0 in 2025.
  • Per Business Quant, the three most recent readings for BOLT's Non Operating Income are $559000.0 (Q3 2025), $649000.0 (Q2 2025), and $1.1 million (Q1 2025).